Dignitana AB (DIGN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Dignitana AB (DIGN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7060
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Dignitana AB (Dignitana), a subsidiary of Eurosund AB, designs, develops, manufactures and markets medical cooling systems.. The company’s DigniCap Scalp Cooling System helps reduce or eliminate hair loss in patients undergoing chemotherapy. The DigniCap system comprises a silicone cap and a connected cooling and controlling unit. It controls the temperature of the cooling cap by cooling the DigniCool coolant in the cooling and controlling unit to a suitable temperature. Dignitana’s scalp cooling technology is patented in Europe, Japan and the US. Its colling systems find application in hospitals, healthcare institutions, and medical centers. The company operates in Sweden and the US. Dignitana is headquartered in Lund, Scania, Sweden.

Dignitana AB (DIGN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Dignitana AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Dignitana AB, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Dignitana AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Dignitana AB, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Dignitana AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Dignitana AB, Medical Equipment, Deal Details 10
Asset Purchase 10
BrainCool Acquires Assets of Benechill for USD2.2 Million 10
Partnerships 11
Dignitana Enters into Agreement with Boa Technology 11
Equity Offering 12
Dignitana Raises USD5 Million in Rights Offering of Shares 12
BrainCool Raises USD5.5 Million in Rights Offering of Shares 13
BrainCool Raises USD1.78 Million in Offering of Shares 14
Dignitana to Raise up to USD4 Million in Private Placement of Shares 15
Dignitana to Raise up to USD2.4 Million in Rights Offering of Shares 17
Dignitana to Raise USD3.37 Million in Private Placement of Units 19
Dignitana to Raise USD2.3 Million in Rights Offering 20
Debt Offering 21
BrainCool to Raise USD2.4 Million in Private Placement of Notes Due 2018 21
Dignitana AB – Key Competitors 22
Dignitana AB – Key Employees 23
Dignitana AB – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Aug 21, 2018: Dignitana publishes interim report for Q2 2018 25
May 22, 2018: Dignitana publishes Interim Financial Report for Q1 2018 26
Feb 22, 2018: Dignitana Publishes Year End Financial Report 2017 27
Aug 24, 2017: Dignitana publish interim financial report for Q2, 2017 32
May 24, 2017: Dignitana publish interim financial report for Q1, 2017 35
Feb 23, 2017: Dignitana publishes Year End Financial Report 2016 37
Corporate Communications 39
Mar 09, 2018: Dignitana Appoints Three Board Members in U.S. And Names James McKinney President and Chief Operating Officer 39
Feb 28, 2018: Dignitana Announces Changes to Board of Directors 41
Other Significant Developments 43
Jul 20, 2018: Dignitana grows business in italy 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Dignitana AB, Medical Equipment, Key Facts, 2017 2
Dignitana AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Dignitana AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Dignitana AB, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Dignitana AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Dignitana AB, Deals By Market, 2012 to YTD 2018 8
Dignitana AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
BrainCool Acquires Assets of Benechill for USD2.2 Million 10
Dignitana Enters into Agreement with Boa Technology 11
Dignitana Raises USD5 Million in Rights Offering of Shares 12
BrainCool Raises USD5.5 Million in Rights Offering of Shares 13
BrainCool Raises USD1.78 Million in Offering of Shares 14
Dignitana to Raise up to USD4 Million in Private Placement of Shares 15
Dignitana to Raise up to USD2.4 Million in Rights Offering of Shares 17
Dignitana to Raise USD3.37 Million in Private Placement of Units 19
Dignitana to Raise USD2.3 Million in Rights Offering 20
BrainCool to Raise USD2.4 Million in Private Placement of Notes Due 2018 21
Dignitana AB, Key Competitors 22
Dignitana AB, Key Employees 23
Dignitana AB, Subsidiaries 24

List of Figures
Dignitana AB, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Dignitana AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Dignitana AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Dignitana AB, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Dignitana AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Dignitana AB, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Dignitana AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Dignitana AB, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Dignitana AB (DIGN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Al Salam Bank BSC (SALAM):企業の財務・戦略的SWOT分析
    Al Salam Bank BSC (SALAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Fenner PLC (FENR):企業の財務・戦略的SWOT分析
    Summary Fenner PLC (Fenner), a subsidiary of Michelin SCA, is a provider of reinforced polymer technology. The company operates in the areas of advanced engineered products and engineered conveyor solutions. Its product portfolio includes heavyweight conveyor belt, high performance polymer component …
  • Courtagen Life Sciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Courtagen Life Sciences Inc (Courtagen) is a medical device company that provides neurological treatment solutions. The company’s products include neuro-development panels, lysosomal disorder panels, syndrome panels, comprehensive epilepsy panels, focus epilepsy panels, metabolism test equip …
  • RentPath LLC:企業の戦略的SWOT分析
    RentPath LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • ROHM Co Ltd (6963):企業の財務・戦略的SWOT分析
    ROHM Co Ltd (6963) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Shop Direct Holdings Limited:企業の戦略・SWOT・財務情報
    Shop Direct Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Shop Direct Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • eResearchTechnology Inc:企業の戦略的SWOT分析
    eResearchTechnology Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • LivePerson, Inc. (LPSN):企業の財務・戦略的SWOT分析
    LivePerson, Inc. (LPSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Glorious Sun Enterprises Limited (393):企業の財務・戦略的SWOT分析
    Glorious Sun Enterprises Limited (393) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Blood Cell Storage Inc:医療機器:M&Aディール及び事業提携情報
    Summary Blood Cell Storage Inc (BCSI) is a medical device company that discovers and develops bio-medical technology products. The company’s products comprise IVF safe sens, platelets ph safe, and nucleic acid extraction systems, among others. Its IVF safe sens comprise trackstation and in-vessel mo …
  • Imvescor Restaurant Group Inc:戦略・SWOT・企業財務分析
    Imvescor Restaurant Group Inc - Strategy, SWOT and Corporate Finance Report Summary Imvescor Restaurant Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Inabata & Co Ltd (8098):企業の財務・戦略的SWOT分析
    Inabata & Co Ltd (8098) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Bloomin’ Brands Inc:企業の戦略・SWOT・財務分析
    Bloomin' Brands Inc - Strategy, SWOT and Corporate Finance Report Summary Bloomin' Brands Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • PT Tigaraksa Satria Tbk (TGKA):企業の財務・戦略的SWOT分析
    PT Tigaraksa Satria Tbk (TGKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Rallis India Ltd (RALLIS):企業の財務・戦略的SWOT分析
    Summary Rallis India Ltd (Rallis), a subsidiary of Tata Chemicals Ltd, is an agri-solutions service provider. The company’s business portfolio includes domestic crop protection, international business, contract manufacturing, seeds, plant growth nutrients and agri services. It offers products such a …
  • EuroSibEnergo Plc:企業の戦略的SWOT分析
    EuroSibEnergo Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Birdstep Technology ASA:企業のM&A・事業提携・投資動向
    Birdstep Technology ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Birdstep Technology ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Mobidiag Ltd:企業の製品パイプライン分析
    Summary Mobidiag Ltd (Mobidiag) operates as a biotechnology company that develops and markets products for molecular diagnosis of infectious diseases and test kits. The company's products portfolio includes Novodiag, Amplidiag, and Prove-it. Its Amplidiag is a diagnostic test for high-volume screeni …
  • ALK-Abello AS (ALK B)-製薬・医療分野:企業M&A・提携分析
    Summary ALK-Abello A/S (ALK) is a research-oriented pharmaceutical company, which discovers, develops and commercializes immunotherapies for allergy prevention and treatment. It also markets diagnostics and other services to allergy clinics. The company's allergy immunotherapy product portfolio incl …
  • Pacific Biosciences of California Inc (PACB):製薬・医療:M&Aディール及び事業提携情報
    Summary Pacific Biosciences of California Inc (Pacific Biosciences) designs, develops, and manufactures sequencing instruments for solving complex genetic abnormalities. The company’s product portfolio comprises proprietary Phospholinked nucleotides, sequencing systems, analytical software and consu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆